Transfusion · 1981 · 54 citations · 17 references
PharmacyClinical PharmacokineticsPharmacokineticsDrug MetabolismPopulation PharmacokineticsToxicokineticsDrug DispositionDrug Half-lifeBlood Concentration-time ProfilesDrug Elimination Half-lifePharmacokinetic Parameter AnalysisSerum Half-lifeSerum Sampling
The elimination of hydroxyethyl starch (HES) from donor blood was studied following either single or multiple intermittent‐flow centrifugation leukapheresis. Immediately following pheresis, serum HES concentrations fell rapidly. The rate of elimination then slowed with trace amounts of HES persisting for weeks. Pharmaco‐kinetic analysis using a two‐compartment open model revealed an average distribution half‐life and terminal half‐life of 3.84 and 48 days, respectively. After multiple phereses, HES accumulated in serum. Although the pattern of elimination was similar, the persistence of HES was more protracted, with the serum level predicted to reach the baseline at 72 weeks pastpheresis versus 38 weeks after a single pheresis. The importance in regards to toxicity, if any, of the persistence of trace amounts of HES in donor blood is presently unknown.
17
INCIDENCE AND SEVERITY OF ANAPHYLACTOID REACTIONS TO COLLOID VOLUME SUBSTITUTES
Johannes Ring · The Lancet · 1977 · 1.3K citations
Intravascular Persistence of Hydroxyethyl Starch in Man
Jim C. Boon, F. Jesch, J. Ring · European Surgical Research · 2008 · 93 citations
Intravascular persistence, tissue storage, and excretion of hydroxyethyl starch.
Thompson Wl, Takashi Fukushima, Rutherford Rb et al. · PubMed · 1970 · 93 citations
A clinical physiologic study of hydroxyethyl starch.
W. S. METCALF, A. Papadopoulos, R. TUFARO et al. · PubMed · 1970 · 73 citations